medigraphic.com
ISSN 2007-8560 (Print)
Órgano Oficial de Difusión Científica de la Federación Mexicana de Colegios de Ortopedia y Traumatología, A.C. (FEMECOT)

2020, Number 2

<< Back Next >>

Ortho-tips 2020; 16 (2)

Coronavirus, the epidemic that changed the world

López AL, Padilla RLG, Garín ZDE, Dittmar JM

Language: Spanish
References: 25
Page: 54-61
PDF size: 202.95 Kb.


ABSTRACT

In December 2019 a new disease occurred in China that has presented a global spread. Currently affecting more than 4 million and causing the death of more than 300 thousand people. With a mortality rate that goes above 13% in several countries in Europe. Most patients have mild symptoms and a good prognosis. The most common manifestations are fever, dry cough, dyspnea, myalgia, headache, fatigue. Other findings are a decrease in lymphocytes in the blood, a high ferritin index and radiographic evidence of pneumonia, with an atypical infiltrate due to diffuse alveolar damage, believed to be an interstitial inflammation, thromboembolism. There is involvement of various organs, and in many cases disseminated intravascular coagulation (DIC), with involvement of the vascular endothelium. The stress associated with fracture and surgical treatment can generate an oxidative stress response. Increasing the expression of inflammatory factors and decreasing the patient’s immunity, increasing the risk of death from COVID-19. The objective of this document is to be a guide for the Orthopedist to care for and protect the surgical team and the patient, knowing the risks of surgical treatment, good use and management of the placement equipment and osteosynthesis material. And the surgical procedures that can be performed during this pandemic, with the aim of reducing risks of contagion and death in patients and in health workers.


REFERENCES

  1. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323 (11): 1061-1069.

  2. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579 (7798): 270-273.

  3. Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020; 395: 689-697.

  4. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China. N Engl J Med. 2020; 382 (8): 727-733.

  5. Nanshan C, Min Z, Xuan D, Jieming Q, Fengyun G, Yang H, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395: 507-513.

  6. Yoo JH, Hong ST. The outbreak cases with the novel coronavirus suggest upgraded quarantine and isolation in Korea. J Korean Med Sci. 2020; 35 (5): e62.

  7. Moran K. Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in Korea. Special article. Epidemiol Health. 2020; 42: e2020007.

  8. Chang-Liang Z, Wang W, Murphy D, Hoi-Po-Hui J. Novel coronavirus and orthopedic surgery. Early experiences from Singapore. J Bone Joint Surg Am. 2020; 102: 745-749.

  9. López-Gatell RH. Comunicado Técnico Diario. Unidad de inteligencia Epidemiológica y Sanitaria (Internet). Subsecretaría de Prevención y Promoción de la Salud. Secretaría de Salud. Gobierno de México 2020. (Citado el 09 de mayo 2020). Disponible en https://www.gob.mx/salud.

  10. Montero FA, Maseda E, Adalia BR, Aguilar G, González de Castro R, Gómez-Herreras JI, et al. Recomendaciones prácticas para el manejo perioperatorio del paciente con sospecha o infección grave por coronavirus SARS-CoV2. Rev Esp Anestesiol Reanim. 2020; 67 (5): 253-260.

  11. University of Medicine Johns Hopkins. Coronavirus Resource Center. COVID-19 Case Tracker (Internet). Baltimore, Maryland. Estados Unidos. https://www.jhu.edu. 2020. (Actualizado 09 de mayo 2020). Available in: https://coronavirus.jhu.edu.

  12. Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. Washington State 2019-nCoV case investigation team. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020; 382 (10): 929-936.

  13. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese center for disease control and prevention. JAMA. 2020; 323 (13): 1239-1242.

  14. Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China. Euro Surveill. 2020; 25 (5): 2000062. doi: 10.2807/1560-7917.

  15. Li H, Liu L, Zhang D, Xu J, Dai H, Tang N, et al. SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet. 2020; PubMed PMID: 32311318.

  16. Shaoqing, L, Fang J, Wating S, Chang C, Jingli C, Wei M, et al. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. E Clinical Medicine (2020). Article in press.

  17. Phan LT, Nguyen TV, Luong QC, Nguyen TV, Nguyen HT. Importation and human-to-human transmission of a novel coronavirus in Vietnam. N Engl J Med. 2020; 382 (9): 872-874.

  18. Bobin M, Lang C, Yuan X, Hang X, Wu Z, Guohui L. Characteristics and early prognosis of COVID-19 infection in fracture patients. J Bone Joint Surg Am. 2020; 102 (9): 750-758.

  19. HIP ATTACK Investigators. Accelerated surgery versus standard care in hip fracture (HIP ATTACK): an international, randomised, controlled trial. Lancet. 2020; 29: 395(10225):698-708.

  20. Lizaur UA, Lopez PFA. Hip attack for hip fractures: is ultra-early surgery necessary? Lancet. 2020; 395 (10225): 661-662.

  21. Ravi B, Pincus D, Wasserstein D, Govindarajan A, Huang A, Austin PC, et al. Association of overlapping surgery with increased risk for complications following hip surgery: a population-based, matched cohort study. JAMA Intern Med. 2018; 178 (1): 75-83.

  22. Klasse PJ. Neutralization of virus infectivity by antibodies: old problems in new perspectives. Adv Biol. 2014; 2014: 157895. doi: 10.1155/2014/157895.

  23. Coughlin MM, Prabhakar BS. Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential. Rev Med Virol. 2012; 22: 2-17.

  24. Zhou G, Zhao Q. Perspectives on therapeutic neutralizing antibodies against the Novel Coronavirus SARS-CoV-2. Int J Biol Sci. 2020; 16 (10): 1718-1723. doi: 10.7150/ijbs.45123.

  25. De Vitis R, Passiatore M, Perna A, Proietti L, Taccardo G. COVID-19 contagion and contamination through hands of trauma patients: what risks and what precautions? J Hosp Infect. 2020; 105(2): 354-355.




2020     |     www.medigraphic.com